Literature DB >> 28538126

Anti-Interleukin-31 Receptor A Antibody for Atopic Dermatitis.

Thomas Ruzicka1, Ryosuke Mihara2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28538126     DOI： 10.1056/NEJMc1704013

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  14 in total

1.  Substance P and IL-33 administered together stimulate a marked secretion of IL-1β from human mast cells, inhibited by methoxyluteolin.

Authors:  Alexandra Taracanova; Irene Tsilioni; Pio Conti; Errol R Norwitz; Susan E Leeman; Theoharis C Theoharides
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-19       Impact factor: 11.205

2.  Interleukin 33 and interleukin 4 regulate interleukin 31 gene expression and secretion from human laboratory of allergic diseases 2 mast cells stimulated by substance P and/or immunoglobulin E.

Authors:  Anastasia I Petra; Irene Tsilioni; Alexandra Taracanova; Alexandra Katsarou-Katsari; Theoharis C Theoharides
Journal:  Allergy Asthma Proc       Date:  2018-03-01       Impact factor: 2.587

3.  Report from the National Institute of Allergy and Infectious Diseases workshop on "Atopic dermatitis and the atopic march: Mechanisms and interventions".

Authors:  Wendy F Davidson; Donald Y M Leung; Lisa A Beck; Cecilia M Berin; Mark Boguniewicz; William W Busse; Talal A Chatila; Raif S Geha; James E Gern; Emma Guttman-Yassky; Alan D Irvine; Brian S Kim; Heidi H Kong; Gideon Lack; Kari C Nadeau; Julie Schwaninger; Angela Simpson; Eric L Simpson; Jonathan M Spergel; Alkis Togias; Ulrich Wahn; Robert A Wood; Judith A Woodfolk; Steven F Ziegler; Marshall Plaut
Journal:  J Allergy Clin Immunol       Date:  2019-01-09       Impact factor: 10.793

4.  Interleukin-31, a Potent Pruritus-Inducing Cytokine and Its Role in Inflammatory Disease and in the Tumor Microenvironment.

Authors:  Alain H Rook; Kathryn A Rook; Daniel J Lewis
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Interventions for chronic pruritus of unknown origin.

Authors:  Andrea Andrade; Chii Yang Kuah; Juliana Esther Martin-Lopez; Shunjie Chua; Volha Shpadaruk; Gloria Sanclemente; Juan Va Franco
Journal:  Cochrane Database Syst Rev       Date:  2020-01-25

Review 6.  Dermatitis Herpetiformis: Novel Perspectives.

Authors:  Emiliano Antiga; Roberto Maglie; Lavinia Quintarelli; Alice Verdelli; Diletta Bonciani; Veronica Bonciolini; Marzia Caproni
Journal:  Front Immunol       Date:  2019-06-11       Impact factor: 7.561

Review 7.  Patient-Reported Outcome Measures in Atopic Dermatitis and Chronic Hand Eczema in Adults.

Authors:  Amy Barrett; Julie Hahn-Pedersen; Nana Kragh; Emily Evans; Ari Gnanasakthy
Journal:  Patient       Date:  2019-10       Impact factor: 3.883

8.  IL-33/IL-31 Axis in Immune-Mediated and Allergic Diseases.

Authors:  Giuseppe Murdaca; Monica Greco; Alessandro Tonacci; Simone Negrini; Matteo Borro; Francesco Puppo; Sebastiano Gangemi
Journal:  Int J Mol Sci       Date:  2019-11-22       Impact factor: 5.923

Review 9.  Primary Localized Cutaneous Amyloidosis of Keratinocyte Origin: An Update with Emphasis on Atypical Clinical Variants.

Authors:  Lamiaa Hamie; Isabelle Haddad; Nourhane Nasser; Mazen Kurban; Ossama Abbas
Journal:  Am J Clin Dermatol       Date:  2021-07-21       Impact factor: 7.403

10.  IL-31 transgenic mice show reduced allergen-induced lung inflammation.

Authors:  Theresa Neuper; Daniel Neureiter; Muamera Sarajlic; Helen Strandt; Renate Bauer; Harald Schwarz; Patrick Suchanek; Evgeniia Korotchenko; Stacey R Dillon; Peter Hammerl; Angelika Stoecklinger; Richard Weiss; Jutta Horejs-Hoeck
Journal:  Eur J Immunol       Date:  2020-07-21       Impact factor: 6.688
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.